Safety and Tolerability Studies for an Anti-Fibrin P2 Monoclonal Antibody for the Treatment of Alzheimer's Disease

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
JEFFREY
Principal Investigator Last Name
STAVENHAGEN
Awardee Organization
Awardee State
Contact PI Country
Project Detail
FY Overall Cost
$1,017,452
Funding Organization
Agency/Funding Organization
Funding Organization Country
Program Official